Skip to main content
A

ABLYNX - Investor Relations & Filings

Delisted Jun 2018 · Acquired / Merged Acquired / Merged The company was acquired by or merged into another entity, so its shares stopped trading independently.
ISIN · BE0003877942 LEI · 549300ZL08QVVII6W560 Professional, scientific and technical activities
Open in API
Filings indexed 759 across all filing types
Latest filing 2018-05-28 Major Shareholding Noti…
Country BE Belgium
Listing —

Recent filings

Filing Released Lang Actions
Press release_Transparency declarations_28 May 2018_ENG.pdf
Major Shareholding Notification Classification · 95% confidence The document is a formal notification regarding changes in major shareholdings (transparency declarations) in accordance with the Belgian Transparency Law. While it mentions M&A activity (Sanofi's acquisition of Ablynx), the primary purpose of this specific release is to announce that several institutional investors have crossed the 3% voting rights threshold. This falls under the definition of a Major Shareholding Notification (MRQ).
2018-05-28 English
Press release_Transparency declarations_28 May 2018_NDL.pdf
Major Shareholding Notification Classification · 95% confidence The document is a regulatory announcement regarding transparency declarations (major shareholding notifications) under Belgian law. It details that several investment firms have crossed the 3% threshold of voting rights. While it mentions the ongoing Sanofi takeover bid, the primary purpose of this specific filing is to disclose changes in significant share ownership, which falls under the 'Major Shareholding Notification' category.
2018-05-28 Dutch
Press release_Transparency declaration Sanofi_28 May 2018_ENG.pdf
Major Shareholding Notification Classification · 95% confidence The document is a formal notification regarding a change in major shareholding (Sanofi crossing the 95% threshold in Ablynx), explicitly citing the 'Transparency Law' and 'Article 14 of the Belgian Law of 2 May 2007'. While it discusses M&A context (the Sanofi takeover bid), the primary purpose of this specific filing is to report the crossing of a major shareholding threshold, which falls under the 'Major Shareholding Notification' category.
2018-05-28 English
Press release_Transparency declaration Sanofi_28 May 2018_NDL.pdf
Major Shareholding Notification Classification · 95% confidence The document is a formal notification regarding a change in significant share ownership (Sanofi S.A. crossing the 95% threshold in Ablynx). It explicitly references Article 14 of the Belgian Transparency Law regarding the disclosure of major shareholdings. While it discusses the ongoing takeover bid (M&A context), the primary purpose of this specific filing is to notify the market of a change in shareholding percentage, which falls under the 'Major Shareholding Notification' category.
2018-05-28 Dutch
175628_Viking_Change of Control Notice_EN_final.pdf
Capital/Financing Update Classification · 90% confidence The document is a formal notice regarding a 'Change of Control' event following a takeover bid by Sanofi. It details the implications for convertible bondholders, including conversion rights and redemption options. While it discusses M&A activity, it is specifically a notice to bondholders regarding the impact of the completed acquisition on their financial instruments, rather than the M&A announcement itself. Given the focus on capital structure and financing terms (convertible bonds), it fits best under Capital/Financing Update.
2018-05-25 English
175628_Viking_Change of Control Notice_NL_final.pdf
Regulatory Filings Classification · 95% confidence The document is a formal 'Change of Control Notice' issued by Ablynx following its acquisition by Sanofi. It details the implications for holders of convertible bonds, specifically regarding conversion rights and put options triggered by the change of control. While it discusses M&A activity, it is not a merger proposal or takeover bid announcement itself (which would be TAR), but rather a post-acquisition regulatory notice regarding existing financial instruments. It does not fit into financial reporting categories like 10-K or IR, nor is it a simple publication announcement. Given its nature as a regulatory disclosure regarding corporate actions and financial instruments, it falls under the RNS (Regulatory Filings) category.
2018-05-25 Dutch

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.